| __timestamp | Bausch Health Companies Inc. | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 1513000 |
| Thursday, January 1, 2015 | 582800000 | 12573000 |
| Friday, January 1, 2016 | 455000000 | 42238000 |
| Sunday, January 1, 2017 | 366000000 | 69800000 |
| Monday, January 1, 2018 | 414000000 | 113773000 |
| Tuesday, January 1, 2019 | 471000000 | 179362000 |
| Wednesday, January 1, 2020 | 452000000 | 266946000 |
| Friday, January 1, 2021 | 465000000 | 438633000 |
| Saturday, January 1, 2022 | 529000000 | 461645000 |
| Sunday, January 1, 2023 | 604000000 | 387332000 |
| Monday, January 1, 2024 | 320653000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, CRISPR Therapeutics AG and Bausch Health Companies Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Bausch Health's R&D expenses grew by approximately 145%, peaking in 2023. This steady increase underscores their strategic focus on expanding their research capabilities. In contrast, CRISPR Therapeutics AG, a pioneer in gene editing, saw a staggering increase of over 25,000% in R&D spending, reflecting their rapid growth and commitment to cutting-edge technology.
While Bausch Health's R&D expenses remained relatively stable, CRISPR's fluctuated, with a notable peak in 2022. These trends highlight the dynamic nature of biotech investments and the varying strategies companies employ to stay at the forefront of innovation.
Comparing Innovation Spending: AbbVie Inc. and Bausch Health Companies Inc.
argenx SE or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Comparing Innovation Spending: Viatris Inc. and CRISPR Therapeutics AG
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Exelixis, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc.
CRISPR Therapeutics AG vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: CRISPR Therapeutics AG and Evotec SE